ID   PTPA_HUMAN              Reviewed;         358 AA.
AC   Q15257; A2A347; A9IZU4; B4DXM4; Q15258; Q53GZ3; Q5TZQ2; Q9BUK1; Q9NNZ7;
AC   Q9NNZ8; Q9NNZ9;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   26-FEB-2020, entry version 182.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A activator;
DE            EC=5.2.1.8;
DE   AltName: Full=PP2A, subunit B', PR53 isoform;
DE   AltName: Full=Phosphotyrosyl phosphatase activator;
DE            Short=PTPA;
DE   AltName: Full=Serine/threonine-protein phosphatase 2A regulatory subunit 4;
DE   AltName: Full=Serine/threonine-protein phosphatase 2A regulatory subunit B';
GN   Name=PTPA {ECO:0000312|HGNC:HGNC:9308}; Synonyms=PPP2R4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Heart;
RX   PubMed=8195217;
RA   Cayla X., Van Hoof C., Bosch M., Waelkens E., Peeters B., Merlevede W.,
RA   Goris J.;
RT   "Molecular cloning, expression, and characterization of PTPA, a protein
RT   that activates the tyrosyl phosphatase activity of protein phosphatase
RT   2A.";
RL   J. Biol. Chem. 269:15668-15675(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Blood;
RX   PubMed=8530035; DOI=10.1006/geno.1995.1140;
RA   Van Hoof C., Aly M., Garcia A., Cayla X., Cassiman J.-J., Merlevede W.,
RA   Goris J.;
RT   "Structure and chromosomal localization of the human gene of the
RT   phosphotyrosyl phosphatase activator (PTPA) of protein phosphatase 2A.";
RL   Genomics 28:261-272(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 2; 3 AND 4).
RX   PubMed=10880964; DOI=10.1046/j.1432-1327.2000.01486.x;
RA   Janssens V., van Hoof C., Martens E., de Baere I., Merlevede W., Goris J.;
RT   "Identification and characterization of alternative splice products encoded
RT   by the human phosphotyrosyl phosphatase activator gene.";
RL   Eur. J. Biochem. 267:4406-4413(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT LEU-357.
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   FUNCTION IN APOPTOSIS, AND SUBCELLULAR LOCATION.
RX   PubMed=17333320; DOI=10.1007/s10495-006-0050-8;
RA   Azam S., Drobetsky E., Ramotar D.;
RT   "Overexpression of the cis/trans isomerase PTPA triggers caspase 3-
RT   dependent apoptosis.";
RL   Apoptosis 12:1243-1255(2007).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 22-358.
RX   PubMed=16782712; DOI=10.1074/jbc.c600100200;
RA   Magnusdottir A., Stenmark P., Flodin S., Nyman T., Hammarstroem M., Ehn M.,
RA   Bakali H M.A., Berglund H., Nordlund P.;
RT   "The crystal structure of a human PP2A phosphatase activator reveals a
RT   novel fold and highly conserved cleft implicated in protein-protein
RT   interactions.";
RL   J. Biol. Chem. 281:22434-22438(2006).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 20-357.
RX   PubMed=16885030; DOI=10.1016/j.molcel.2006.07.008;
RA   Leulliot N., Vicentini G., Jordens J., Quevillon-Cheruel S., Schiltz M.,
RA   Barford D., van Tilbeurgh H., Goris J.;
RT   "Crystal structure of the PP2A phosphatase activator: implications for its
RT   PP2A-specific PPIase activity.";
RL   Mol. Cell 23:413-424(2006).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS), FUNCTION IN MODULATION OF PP2A
RP   SUBSTRATE SPECIFICITY, ATP-BINDING, MUTAGENESIS OF ASP-185; ALA-239;
RP   GLY-240; VAL-244; GLU-305; GLY-325; MET-329 AND LYS-337, AND INTERACTION
RP   WITH THE PP2A(D) COMPLEX.
RX   PubMed=16916641; DOI=10.1016/j.molcel.2006.07.027;
RA   Chao Y., Xing Y., Chen Y., Xu Y., Lin Z., Li Z., Jeffrey P.D., Stock J.B.,
RA   Shi Y.;
RT   "Structure and mechanism of the phosphotyrosyl phosphatase activator.";
RL   Mol. Cell 23:535-546(2006).
CC   -!- FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the
CC       cis-trans isomerization of proline imidic peptide bonds in
CC       oligopeptides. Acts as a regulatory subunit for serine/threonine-
CC       protein phosphatase 2A (PP2A) modulating its activity or substrate
CC       specificity, probably by inducing a conformational change in the
CC       catalytic subunit, a proposed direct target of the PPIase. Can
CC       reactivate inactive phosphatase PP2A-phosphatase methylesterase
CC       complexes (PP2A(i)) in presence of ATP and Mg(2+) (By similarity).
CC       Reversibly stimulates the variable phosphotyrosyl phosphatase activity
CC       of PP2A core heterodimer PP2A(D) in presence of ATP and Mg(2+) (in
CC       vitro). The phosphotyrosyl phosphatase activity is dependent of an
CC       ATPase activity of the PP2A(D):PPP2R4 complex. Is involved in
CC       apoptosis; the function appears to be independent from PP2A.
CC       {ECO:0000250, ECO:0000269|PubMed:16916641,
CC       ECO:0000269|PubMed:17333320}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[protein]-peptidylproline (omega=180) = [protein]-
CC         peptidylproline (omega=0); Xref=Rhea:RHEA:16237, Rhea:RHEA-
CC         COMP:10747, Rhea:RHEA-COMP:10748, ChEBI:CHEBI:83833,
CC         ChEBI:CHEBI:83834; EC=5.2.1.8;
CC   -!- SUBUNIT: Associates with PP2A heterodimeric core enzyme PP2A(D),
CC       composed of a 36 kDa catalytic subunit (subunit C) and a 65 kDa
CC       constant regulatory subunit (PR65 or subunit A) (PubMed:16916641).
CC       Interacts with PPP2CB (By similarity). {ECO:0000250|UniProtKB:P58389,
CC       ECO:0000269|PubMed:16916641}.
CC   -!- INTERACTION:
CC       Q4VCS5-2:AMOT; NbExp=3; IntAct=EBI-1774121, EBI-3891843;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17333320}. Nucleus
CC       {ECO:0000269|PubMed:17333320}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=2; Synonyms=Beta;
CC         IsoId=Q15257-1; Sequence=Displayed;
CC       Name=1; Synonyms=Alpha;
CC         IsoId=Q15257-2; Sequence=VSP_005123;
CC       Name=3; Synonyms=Delta;
CC         IsoId=Q15257-3; Sequence=VSP_005122;
CC       Name=4; Synonyms=Epsilon;
CC         IsoId=Q15257-4; Sequence=VSP_005124;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- SIMILARITY: Belongs to the PTPA-type PPIase family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PPP2R4ID41817ch9q34.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X73478; CAA51873.1; -; mRNA.
DR   EMBL; X86428; CAA60163.1; -; Genomic_DNA.
DR   EMBL; X86429; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86430; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86432; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86434; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86435; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86436; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86437; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86438; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86439; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86428; CAB77601.1; -; Genomic_DNA.
DR   EMBL; X86429; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86430; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86431; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86432; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86434; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86435; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86436; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86437; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86438; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86439; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86428; CAB77602.1; -; Genomic_DNA.
DR   EMBL; X86429; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86432; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86434; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86435; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86436; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86437; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86438; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86439; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86428; CAB77603.1; -; Genomic_DNA.
DR   EMBL; X86429; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; X86430; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; X86434; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; X86435; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; X86436; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; X86437; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; X86438; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; X86439; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; AK302043; BAG63436.1; -; mRNA.
DR   EMBL; BT020119; AAV38922.1; -; mRNA.
DR   EMBL; AK222788; BAD96508.1; -; mRNA.
DR   EMBL; AL158151; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471090; EAW87876.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW87882.1; -; Genomic_DNA.
DR   EMBL; BC002545; AAH02545.1; -; mRNA.
DR   EMBL; BC011605; AAH11605.1; -; mRNA.
DR   CCDS; CCDS65156.1; -. [Q15257-3]
DR   CCDS; CCDS6920.1; -. [Q15257-2]
DR   PIR; A54021; A54021.
DR   RefSeq; NP_001180326.1; NM_001193397.1.
DR   RefSeq; NP_001258761.1; NM_001271832.1. [Q15257-3]
DR   RefSeq; NP_066954.2; NM_021131.4. [Q15257-2]
DR   RefSeq; NP_821067.1; NM_178000.2. [Q15257-2]
DR   RefSeq; NP_821068.1; NM_178001.2. [Q15257-1]
DR   RefSeq; NP_821070.1; NM_178003.2. [Q15257-4]
DR   PDB; 2G62; X-ray; 1.60 A; A=22-358.
DR   PDB; 2HV6; X-ray; 1.90 A; A/B=1-358.
DR   PDB; 2HV7; X-ray; 2.50 A; A/B/C/D/E/F/G/H=1-358.
DR   PDB; 2IXM; X-ray; 1.50 A; A=20-357.
DR   PDB; 4LAC; X-ray; 2.82 A; B=19-358.
DR   PDB; 4NY3; X-ray; 1.80 A; A/B=22-358.
DR   PDBsum; 2G62; -.
DR   PDBsum; 2HV6; -.
DR   PDBsum; 2HV7; -.
DR   PDBsum; 2IXM; -.
DR   PDBsum; 4LAC; -.
DR   PDBsum; 4NY3; -.
DR   SMR; Q15257; -.
DR   BioGrid; 111516; 75.
DR   IntAct; Q15257; 21.
DR   STRING; 9606.ENSP00000377036; -.
DR   BindingDB; Q15257; -.
DR   ChEMBL; CHEMBL2505; -.
DR   iPTMnet; Q15257; -.
DR   PhosphoSitePlus; Q15257; -.
DR   SwissPalm; Q15257; -.
DR   BioMuta; PTPA; -.
DR   DMDM; 116242737; -.
DR   OGP; Q15257; -.
DR   CPTAC; CPTAC-259; -.
DR   CPTAC; CPTAC-260; -.
DR   EPD; Q15257; -.
DR   jPOST; Q15257; -.
DR   MassIVE; Q15257; -.
DR   MaxQB; Q15257; -.
DR   PeptideAtlas; Q15257; -.
DR   PRIDE; Q15257; -.
DR   ProteomicsDB; 60499; -. [Q15257-1]
DR   ProteomicsDB; 60500; -. [Q15257-2]
DR   ProteomicsDB; 60501; -. [Q15257-3]
DR   ProteomicsDB; 60502; -. [Q15257-4]
DR   DNASU; 5524; -.
DR   Ensembl; ENST00000337738; ENSP00000337448; ENSG00000119383. [Q15257-1]
DR   Ensembl; ENST00000355007; ENSP00000347109; ENSG00000119383. [Q15257-4]
DR   Ensembl; ENST00000357197; ENSP00000349726; ENSG00000119383. [Q15257-3]
DR   Ensembl; ENST00000358994; ENSP00000351885; ENSG00000119383. [Q15257-2]
DR   Ensembl; ENST00000393370; ENSP00000377036; ENSG00000119383. [Q15257-2]
DR   GeneID; 5524; -.
DR   KEGG; hsa:5524; -.
DR   UCSC; uc004bxl.3; human. [Q15257-1]
DR   CTD; 5524; -.
DR   DisGeNET; 5524; -.
DR   GeneCards; PTPA; -.
DR   HGNC; HGNC:9308; PTPA.
DR   HPA; CAB022068; -.
DR   HPA; CAB035999; -.
DR   HPA; HPA005695; -.
DR   MIM; 600756; gene.
DR   neXtProt; NX_Q15257; -.
DR   OpenTargets; ENSG00000119383; -.
DR   PharmGKB; PA33671; -.
DR   GeneTree; ENSGT00390000011500; -.
DR   InParanoid; Q15257; -.
DR   KO; K17605; -.
DR   OMA; TGWGDCC; -.
DR   OrthoDB; 1165705at2759; -.
DR   PhylomeDB; Q15257; -.
DR   TreeFam; TF105555; -.
DR   SIGNOR; Q15257; -.
DR   ChiTaRS; PTPA; human.
DR   EvolutionaryTrace; Q15257; -.
DR   GeneWiki; PPP2R4; -.
DR   GenomeRNAi; 5524; -.
DR   Pharos; Q15257; Tchem.
DR   PRO; PR:Q15257; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q15257; protein.
DR   Bgee; ENSG00000119383; Expressed in endometrium epithelium and 234 other tissues.
DR   ExpressionAtlas; Q15257; baseline and differential.
DR   Genevisible; Q15257; HS.
DR   GO; GO:0034704; C:calcium channel complex; IDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IDA:HGNC-UCL.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:HGNC-UCL.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IDA:HGNC-UCL.
DR   GO; GO:0019888; F:protein phosphatase regulator activity; IDA:HGNC-UCL.
DR   GO; GO:0008160; F:protein tyrosine phosphatase activator activity; IDA:HGNC-UCL.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:BHF-UCL.
DR   GO; GO:0007052; P:mitotic spindle organization; IBA:GO_Central.
DR   GO; GO:0032515; P:negative regulation of phosphoprotein phosphatase activity; IDA:HGNC-UCL.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; IDA:HGNC-UCL.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IDA:HGNC-UCL.
DR   GO; GO:0035307; P:positive regulation of protein dephosphorylation; IDA:HGNC-UCL.
DR   GO; GO:0043666; P:regulation of phosphoprotein phosphatase activity; IDA:HGNC-UCL.
DR   CDD; cd04087; PTPA; 1.
DR   InterPro; IPR004327; Phstyr_phstse_ac.
DR   InterPro; IPR037218; PTPA_sf.
DR   PANTHER; PTHR10012; PTHR10012; 1.
DR   Pfam; PF03095; PTPA; 1.
DR   PIRSF; PIRSF016325; Phstyr_phstse_ac; 1.
DR   SUPFAM; SSF140984; SSF140984; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding; Cytoplasm;
KW   Direct protein sequencing; Isomerase; Nucleotide-binding; Nucleus;
KW   Polymorphism; Reference proteome; Rotamase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   CHAIN           2..358
FT                   /note="Serine/threonine-protein phosphatase 2A activator"
FT                   /id="PRO_0000071524"
FT   NP_BIND         183..189
FT                   /note="ATP"
FT   NP_BIND         240..242
FT                   /note="ATP"
FT   NP_BIND         342..343
FT                   /note="ATP"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   VAR_SEQ         45..108
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_005122"
FT   VAR_SEQ         73..149
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005124"
FT   VAR_SEQ         73..107
FT                   /note="Missing (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:8195217, ECO:0000303|Ref.5,
FT                   ECO:0000303|Ref.6"
FT                   /id="VSP_005123"
FT   VARIANT         28
FT                   /note="K -> R (in dbSNP:rs17481693)"
FT                   /id="VAR_028101"
FT   VARIANT         208
FT                   /note="R -> Q (in dbSNP:rs4836639)"
FT                   /id="VAR_028102"
FT   VARIANT         357
FT                   /note="S -> L (in dbSNP:rs2480452)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_028103"
FT   MUTAGEN         185
FT                   /note="D->A: Impairs ATPase activity of the PP2A(D):PPP2R4
FT                   complex; no effect on interaction with the PP2A(D)
FT                   complex."
FT                   /evidence="ECO:0000269|PubMed:16916641"
FT   MUTAGEN         239
FT                   /note="A->D: Impairs ATPase activity of the PP2A(D):PPP2R4
FT                   complex; no effect on interaction with the PP2A(D)
FT                   complex."
FT                   /evidence="ECO:0000269|PubMed:16916641"
FT   MUTAGEN         240
FT                   /note="G->D: Impairs ATPase activity of the PP2A(D):PPP2R4
FT                   complex; no effect on interaction with the PP2A(D)
FT                   complex."
FT                   /evidence="ECO:0000269|PubMed:16916641"
FT   MUTAGEN         244
FT                   /note="V->D: Impairs interaction with the PP2A(D) complex."
FT                   /evidence="ECO:0000269|PubMed:16916641"
FT   MUTAGEN         305
FT                   /note="E->A: Abolishes interaction with the PP2A(D)
FT                   complex."
FT                   /evidence="ECO:0000269|PubMed:16916641"
FT   MUTAGEN         316
FT                   /note="V->D: Impairs interaction with the PP2A(D) complex."
FT   MUTAGEN         325
FT                   /note="G->D: Abolishes interaction with the PP2A(D)
FT                   complex."
FT                   /evidence="ECO:0000269|PubMed:16916641"
FT   MUTAGEN         329
FT                   /note="M->D: Abolishes interaction with the PP2A(D)
FT                   complex."
FT                   /evidence="ECO:0000269|PubMed:16916641"
FT   MUTAGEN         337
FT                   /note="K->G: Impairs interaction with the PP2A(D) complex."
FT                   /evidence="ECO:0000269|PubMed:16916641"
FT   CONFLICT        113
FT                   /note="V -> L (in Ref. 1; CAA51873, 2; CAA60163 and 3;
FT                   CAB77601/CAB77602)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        297
FT                   /note="Missing (in Ref. 2; CAA60163 and 3; CAB77601/
FT                   CAB77602/CAB77603)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        357
FT                   /note="S -> V (in Ref. 1; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   HELIX           34..40
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           43..58
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   TURN            59..61
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           108..124
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   STRAND          134..136
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           139..156
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           161..166
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           167..175
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   TURN            181..184
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           188..203
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           209..211
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           212..217
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           219..233
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   STRAND          237..240
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           243..245
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   STRAND          247..250
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           253..261
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   TURN            262..264
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           270..274
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           276..282
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           283..285
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           287..298
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           303..306
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           308..313
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           319..333
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   TURN            334..336
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   HELIX           338..341
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   STRAND          348..350
FT                   /evidence="ECO:0000244|PDB:2IXM"
FT   STRAND          352..354
FT                   /evidence="ECO:0000244|PDB:2IXM"
SQ   SEQUENCE   358 AA;  40668 MW;  2A962521AF5B4CF7 CRC64;
     MAEGERQPPP DSSEEAPPAT QNFIIPKKEI HTVPDMGKWK RSQAYADYIG FILTLNEGVK
     GKKLTFEYRV SEMWNEVHEE KEQAAKQSVS CDECIPLPRA GHCAPSEAIE KLVALLNTLD
     RWIDETPPVD QPSRFGNKAY RTWYAKLDEE AENLVATVVP THLAAAVPEV AVYLKESVGN
     STRIDYGTGH EAAFAAFLCC LCKIGVLRVD DQIAIVFKVF NRYLEVMRKL QKTYRMEPAG
     SQGVWGLDDF QFLPFIWGSS QLIDHPYLEP RHFVDEKAVN ENHKDYMFLE CILFITEMKT
     GPFAEHSNQL WNISAVPSWS KVNQGLIRMY KAECLEKFPV IQHFKFGSLL PIHPVTSG
//
